New research results are driving interest in vitamin K2, according to NattoPharma CEO Hogne Vik. But the company has also developed a new, more potent powder form that is helping to raise the ingredient's profile.
With cranberry health claims rejected in the European Union, some players have ventured down the medical devices route where therapeutic claims are possible that would never succeed under the EU’s strict health claim rules. Not a good thing, says Gunter...
Exposing healthy people to modified pathogens in a controlled clinical trial setting could be an exciting new way for industry to overcome the challenges of health claim substantiation, says Nizo Food Research expert.
Arla Foods used to be a Danish dairy with a Scandinavian bent. Now it is global-facing, upping its R&D spend and obsessed with finding out what consumers want, rather than delivering products it thinks they want.
While EFSA’s health claims dossier may pave the way towards tighter regulations on what can and cannot be said about a food's potential benefit, the way that consumers understand and interact with functional foods seems to remain mainly unchanged....
It’s 100 years since Casimir Funk came up with the term ‘vitamin’, but with an ever-increasing global population and negative reports in the media of their ‘ineffectiveness’ for select health conditions, what does the future hold for the humble vitamin?
About 60% of elderly hospital patients in the UK are malnourished according to recent data from the British Dietetic Association, a problem companies like Danish firm Arla Food Ingredients are trying to tackle with a new whey form.
The challenge of getting beneficial omega-3 fatty acids into finished products is a big one for the food ingredients and manufacturing industry. But how can suppliers and manufacturers work to get these ingredients into a wider range of products?